Table 3.
Variables | Univariate HR (95% CI) | p value | Multi-variates HR (95% CI) | p value | ||
---|---|---|---|---|---|---|
General | ||||||
Age ≥ 60 | 1.1 | (0.5–2.8) | 0.79 | |||
Male | 0.7 | (0.3–1.7) | 0.40 | |||
HBV | 0.6 | (0.2–1.5) | 0.27 | |||
HCV | 3.3 | (0.9–13.0) | 0.08 | 2.3 | (0.5–10.0) | 0.26 |
CPS class B | 2.1 | (0.8–5.5) | 0.13 | |||
Nivolumab used | 0.4 | (0.2–1.0) | 0.05 | 0.2 | (0.1–0.7) | 0.01 |
HCC status | ||||||
PVT | 2.9 | (1.1–7.3) | 0.03 | 4.3 | (1.5–12.8) | 0.01 |
Metastasis | 1.0 | (0.4–2.6) | 0.94 | |||
AFP > 400 (ng/mL) | 2.6 | (1.1–6.4) | 0.03 | 3.3 | (1.1–9.3) | 0.03 |
CPS Child–Pugh score, PVT portal vein thrombosis, AFP alpha- fetoprotein